Quarterly ResultMay 28, 2026, 04:09 PM
HealthEquity Q1 Revenue +7.2% to $354.6M; EPS $0.82; $1B Buyback Boost
AI Summary
HealthEquity, Inc. reported strong financial results for the three months ended April 30, 2026, with total revenue increasing by 7.2% to $354.6 million and net income rising by 28.8% to $69.4 million. Diluted earnings per share grew significantly to $0.82. The company also announced a substantial increase of $1.0 billion to its common stock repurchase authorization, having already repurchased $123.0 million during the quarter.
Key Highlights
- Total revenue increased 7.2% to $354.6 million for the three months ended April 30, 2026.
- Net income rose 28.8% to $69.4 million for the three months ended April 30, 2026.
- Diluted EPS increased 34.4% to $0.82 for the three months ended April 30, 2026.
- Net cash provided by operating activities was $97.5 million, up 50.6% year-over-year.
- The board of directors increased the common stock repurchase authorization by $1.0 billion in May 2026.
- The company repurchased $123.0 million of common stock during the quarter.
- HealthEquity is subject to a consolidated putative class action lawsuit and regulatory inquiries related to a fiscal 2025 cybersecurity incident.
Price Impact
More from HQY